secwatch.observer — SEC 8-K summary
======================================

Issuer:     WEST PHARMACEUTICAL SERVICES INC (WST)
CIK:        0000105770
Form:       8-K
Filed at:   2026-03-09T23:59:59+00:00
Accession:  0000105770-26-000041
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 7.01, 99.1, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CEO Eric M. Green to retire; West reaffirms 2026 guidance
---------------------------------------------------------

- Eric M. Green informed Board on March 6, 2026 of plan to retire as President, CEO and Chair after successor is hired, expected H2 2026.
- Board is engaging a leading executive recruiting firm to find successor; transition aimed at smooth handoff.
- Company reaffirms 2026 financial guidance issued on February 12, 2026; no change to outlook.
- Green served as CEO since April 2015, Chair since May 2022; TSR ~350% during his 11-year tenure and sales more than doubled.
- Lead Independent Director Robert F. Friel thanked Green for his service and highlighted company's innovation and pandemic response.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/105770/000010577026000041/0000105770-26-000041-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/105770/000010577026000041/wst-20260309.htm
  HTML page:      https://secwatch.observer/filing/0000105770-26-000041

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer